Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell”

11,138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 11,138 results

Testing effectiveness (Phase 2)UnknownNCT00690963
What this trial is testing

Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AHS Cancer Control Alberta 12
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Not applicableStudy completedNCT01018147
What this trial is testing

4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition

Who this might be right for
Lung Cancer
Virginia Commonwealth University 22
Testing effectiveness (Phase 2)Ended earlyNCT00087048
What this trial is testing

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04655976
What this trial is testing

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 758
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778940
What this trial is testing

Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.

Who this might be right for
Leptomeningeal Metastasis
Tianjin Medical University Cancer Institute and Hospital 50
Early research (Phase 1)UnknownNCT03057340
What this trial is testing

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06563999
What this trial is testing

Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.

Who this might be right for
Lung Cancer Stage IIIMutation
Sun Yat-sen University 120
Not applicableEnded earlyNCT01419587
What this trial is testing

Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Iowa 11
Testing effectiveness (Phase 2)Ended earlyNCT00983047
What this trial is testing

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07601048
What this trial is testing

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Who this might be right for
KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
Shandong Suncadia Medicine Co., Ltd. 450
Testing effectiveness (Phase 2)UnknownNCT04553887
What this trial is testing

Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 53
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00578149
What this trial is testing

Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Dana-Farber Cancer Institute 45
Testing effectiveness (Phase 2)Study completedNCT00244985
What this trial is testing

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 42
Not applicableStudy completedNCT04872621
What this trial is testing

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
AstraZeneca 104
Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Early research (Phase 1)Study completedNCT00731952
What this trial is testing

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Virginia 21
Large-scale testing (Phase 3)UnknownNCT00002858
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 280
Next Page